BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 8077318)

  • 1. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
    Chang YT; Kulin HE; Garibaldi L; Suriano MJ; Bracki K; Pang S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1251-7. PubMed ID: 8077318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H; Zhang L; Yang X; Chang YT; Kappy M; Slover RS; Jorgensen V; Pang S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E; Sanchez R; Simard J; Chang YT; Wang J; Pang S; Labrie F
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new inherited variant of the 3 beta-hydroxysteroid dehydrogenase-isomerase deficiency syndrome: evidence for the existence of two isoenzymes.
    Cravioto MD; Ulloa-Aguirre A; Bermudez JA; Herrera J; Lisker R; Mendez JP; Perez-Palacios G
    J Clin Endocrinol Metab; 1986 Aug; 63(2):360-7. PubMed ID: 3088022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation.
    Lofrano-Porto A; Casulari LA; Nascimento PP; Giacomini L; Naves LA; da Motta LD; Layman LC
    Fertil Steril; 2008 Oct; 90(4):1169-74. PubMed ID: 17961559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperandrogenism due to 3 beta-hydroxysteroid dehydrogenase deficiency with accessory adrenocortical tissue: a hormonal and metabolic evaluation.
    Paula FJ; Dick-de-Paula I; Pontes A; Schmitt FC; Mendonça BB; Foss MC
    Braz J Med Biol Res; 1994 May; 27(5):1149-58. PubMed ID: 8000336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene.
    Caron P; Imbeaud S; Bennet A; Plantavid M; Camerino G; Rochiccioli P
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3563-9. PubMed ID: 10522996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man.
    Sekihara H; Sennett JA; Liddle GW; McKenna TJ; Yarbro LR
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1078-84. PubMed ID: 186475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
    Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty.
    Mendonca BB; Bloise W; Arnhold IJ; Batista MC; Toledo SP; Drummond MC; Nicolau W; Mattar E
    J Steroid Biochem; 1987 Dec; 28(6):669-75. PubMed ID: 2826919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.